
Scientists developed an experimental nasal spray based on extracellular vesicles from the amniotic membrane of the placenta that protected nerve cells, reduced neuroinflammation and improved memory in a mouse model of Alzheimer's disease, and also showed positive effects on human neurons in vitro.
AI-generated summary
Alzheimer's disease is a neurodegenerative disease characterized by loss of memory and cognitive function for which there is currently no effective treatment. Research is focusing on reducing neuroinflammation and protecting neurons as potential therapeutic strategies.
Scientists have developed an experimental nasal spray that protected nerve cells and helped preserve memory in mice with Alzheimer's disease. This was reported by scientists whose work was published in the journal Translational Neurodegeneration (TN).
The spray is based on extracellular vesicles - microscopic bubbles that cells use to transport biologically active substances. The researchers obtained them from the amniotic membrane of the placenta and administered them through the nose to mice with a model of Alzheimer's disease. The particles were able to penetrate the brain and reach the hippocampus, an area important for memory.
The therapy reduced neuroinflammation, protected neurons, and improved the functioning of synapses—the connections through which nerve cells exchange signals. As a result, the animals performed better on tests of spatial, working and recognition memory. Moreover, the treatment helped both prevent the occurrence of memory problems and reduce existing problems. Positive effects were also found in laboratory experiments with human neurons.
According to the authors, the results open up a promising direction for creating treatments for Alzheimer's disease that affect inflammation and the environment surrounding neurons. However, so far the method has only been tested in animal and cell models.
AI outlook — possibilities, not facts
Preclinical trials of the nasal spray will begin in more complex animal models in the coming months
Likely · Within months
If the results are confirmed, the spray could enter Phase I clinical trials in humans in 2-3 years.
Possible · Within years

The Russian instrument PmL-Ch7, installed on the Chinese lunar probe Chang'e-7, will test mathematical models of the movement of lunar dust, including natural and disturbed movement under the influence of space technology. The launch of the mission has been postponed to 2027, the instrument is in the preparation stage. Engineer Dmitry Zarubin from the Institute of Space Research of the Russian Academy of Sciences emphasized the danger of lunar dust for technology and humans due to its toxic effects and levitation above the surface of the Moon.

Scientists have recorded that female Far Eastern leopards in the wild form unrelated pairs to raise kittens together: one hunts, the other stays with the cubs, or they hunt together. Females raise kittens until the age of 1.5 years, after which the cub begins an independent life.

Director of the AI Research Center at UNN Nikolai Zolotykh commented on OpenAI’s statement about solving the Navier-Stokes equation. According to him, this discovery is of fundamental importance, but will not have a significant impact on applied science.

Scientists have found that reducing caloric intake by 30% slows down the accumulation of age-related mutations in the DNA of mice. The effect is most pronounced in the cells of the liver, kidneys and brain, which opens up new perspectives in the study of the mechanisms of aging.

In Finland, in the Päijät-Häme region, a man with a metal detector found a Viking Age treasure weighing 4.5 kg. This is the largest discovery of Late Iron Age silver coins in the country's history, surpassing the previous record in Nousiainen.

Russian scientists are creating a PCR test based on the analysis of RNA from venous blood to assess biological aging in 15 genes. The development is aimed at creating personalized programs for healthy longevity, taking into account individual characteristics.